Recarbrio Injection, Powder, For Solution
Product Images NDC 0006-3856

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Recarbrio (NDC 0006-3856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Recarbrio 01)

Chemical structure diagram depicting the molecular formula of the active ingredient in RECARBRIO, including imipenem anhydrous, cilastatin, and relebactam anhydrous, with associated bonds and functional groups shown.*

FDA Label Image

Chemical Structure (Recarbrio 02)

Chemical structure diagram of the active ingredients imipenem anhydrous, cilastatin, and relebactam anhydrous shown in the image.*

FDA Label Image

Chemical Structure (Recarbrio 03)

Chemical structure of the active ingredient in RECARBRIO: imipenem anhydrous or one of its components, showing atoms, bonds, and a water molecule (H2O). This structural diagram illustrates the molecular configuration relevant to the drug composition.*

FDA Label Image

Principal Display Panel (1.25 g Vial Carton Label)

Label for Recarbrio 1.25 g per vial powder for injection, containing imipenem, cilastatin, and relebactam. The label states it is for intravenous infusion only and must be constituted and further diluted. Pack contains 25 single-dose vials. Labeler is Merck Sharp & Dohme LLC. Storage instructions and barcode are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.